Company
Overview
Leadership
Social Accountability
Technology
RJX Technology
Therapeutic Areas
Pipeline
Clinical Trials
Contact
Contact Us
Join Reven
News
Latest News
Research
Investor Portal
2018/10/26 Reven News Press
October 26, 2018
| Featured
SAD Cohort 5 Completed. SAD Cohort 5B doses subjects; Cohort 5 has finished.
More Reven News Releases
|
More Research & Development